With the reduced IL6 levels, the p-STAT3 expression (Fig. 5K) and the metastatic potential of CRC as indicated by MMP-2 expression (Fig. 5L) were also significantly reduced. The gene discussed is STAT3; the disease is colorectal carcinoma.